Summary
Reported are two cases of patients with central nervous system systemic lupus erythematosus (SLE) with clinical features of a myelopathy confirmed by magnetic resonance imaging (MRI). In one case, further evaluation including Single Photon Emission Computerized Tomography (SPECT) and neuropsychological testing, indicated higher cortical deficits which improved after treatment with monthly pulse intravenous cyclophosphamide. Subsequent cessation of cyclophosphamide was associated with further progression of the neurological disease in this patient.
Similar content being viewed by others
References
Kassan, S.S., Lockshin, M.D. Central nervous system lupus erythematosus. The need for classification. Arthritis Rheum, 1979, 22 (12).
Andrianakos, A., Duffy, J., Suzuki, M., Sharp, J.T. Transverse myelopathy in systemic lupus erythematosus. Report of three cases and review of the literature. Ann Int Med, 1975, 83, 616–624.
Boumpas, D.T., Patronas, J.N., Dalakos, M.C., Hakim, C.A., Klippel, J.H., Balow, J.E. Acute transverse myelitis in systemic lupus erythematosus: Magnetic resonance imaging and review of the literature. J Rheumatol, 1990, 17 (1), 89–92.
Simeon-Aznar, C.P., Tolosa-Vilella, C., Cuenca-Luque, R., Jordana-Comajuncosa, R.J., Ordi-Ros, J., Poosch-Gil, J.A. Transverse myelitis in systemic lupus erythematosus: Two cases with magnetic resonance imaging. Br J Rheumatol 1992, 31, 555–558.
Barile, L., Lavalle, C. Transverse myelitis in systemic lupus erythematosus — The effect of i.v. pulse methylprednisolone and cyclophosphamide. J Rheumatol 1992, 19 (3), 370–372.
Berlanga, B., Rubio, F.R., Moga, I., Pac, V. Response to intravenous cyclophosphamide treatment in lupus myelopathy. J Rheumatol 1992, 19 (5), 829–830.
Denburg, S.D., Carbotte, R.M., Denburg, J.A. Cognitive impairment in systemic lupus erythematosus. A neuropsychological study of individual and group deficits. J Clin Exp Neuropsych, 1987, 9 (4), 323–339.
Ginsburg, K.S., Wright, E.A., Larson, M.G., Fossel, A.H., Albert, M., Schur, P.H., Liang, M.H. A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum, 1992, 35 (7), 776–782.
Nossent, J.C., Hovestadt, A., Schönfeld, D.H.W., Swaak, S.J.G. Single-photon-emission computer tomography of the brain in the evaluation of cerebral lupus. Arthritis Rheum., 1991, 34 (11), 1997–1403.
Emmai, L., Bramati, M., De Cristofaro, M.T.R., Mascalchi, M., Dal Pozzo, G., Marconi, G.P., Massai, G., Passaleva, A. MRI and SPECT investigations of the CNS in SLE patients. Clin Exp Rheumatol, 1993, 11, 13–20.
Kushner, M.J., Tobin, M., Fazekas, F., Chawluk, J., Jamieson, D., Freundlich, B., Grenell, S., Freeman, L., Reivich, M. Cerebral blood flow variation in CNS lupus. Neurology 1990, 40, 99–102.
Neirinck, R.D., Canning, L.R., Piper, I.M., Nowotnik, D.P., Pickett, R.D., Holmes, R.A., Volkert, W.A., Forster, A.M., Weisner, P.S., Marriott, J.A., Chaplin, S.B. Technetium-99m d, 1-HM-PAO: A new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 1987, 28, 191–202.
Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rothfield, N.F., Green Schaller, J., Talal, N., Winchester, R.J. The 1982 Revised Criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25 (11), 1271–1277.
Nakano, I., Mannen, T., Mizutani, T., Yokohari, R. Peripheral white matter lesions of the spinal cord with changes in small arachnoid arteries in systemic lupus erythematosus. Clin Neuropath 1989, 8 (2), 102–108.
Zerbini, C.A.F., Fidelix, T.S.A., Rabello, G.D. Recovery from transverse myelitis of systemic lupus erythematosus with steroid therapy. J Neurol 1986, 233, 488–489.
Warren, R.W., Kredich, D.W. Transverse myelitis and acute central nervous system manifestations of systemic lupus erythematosus. Arthritis Rheum 1987, 30, 947–950.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stahl, H.D., Ettlin, T.H., Plohmann, A. et al. Central nervous system lupus: Concomitant occurrence of myelopathy and cognitive dysfunction. Clin Rheumatol 13, 273–279 (1994). https://doi.org/10.1007/BF02249026
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02249026